Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Haisma

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Blood|June 25, 1998
Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapyH J Haisma, M F Sernee, E Hooijberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2006
Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoterW M Gommans, P M J McLaughlin, J A C Schalk, et al.
Clinical Chemistry|December 1, 1987
Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serumO C Boerman, C M Thomas, M F Segers, et al.
The Biochemical Journal|June 8, 2001
Cloning and characterization of human liver cytosolic beta-glycosidaseM de Graaf, I C van Veen, I H van der Meulen-Muileman, et al.
The Journal of Urology|June 7, 2002
Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancerH G van der Poel, B Molenaar, V W van Beusechem, et al.
International Journal of Cancer|March 17, 2001
Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugateP H Houba, E Boven, I H van der Meulen-Muileman, et al.
British Journal of Cancer|February 24, 2001
A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancerP H Houba, E Boven, I H van der Meulen-Muileman, et al.
Biochemical Pharmacology|February 26, 1999
Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenograftsP H Houba, E Boven, I H van der Meulen-Muileman, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and manH J Haisma, M A Kessel, C Silva, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Blood|June 25, 1998
Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapyH J Haisma, M F Sernee, E Hooijberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2006
Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoterW M Gommans, P M J McLaughlin, J A C Schalk, et al.
Clinical Chemistry|December 1, 1987
Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serumO C Boerman, C M Thomas, M F Segers, et al.
The Biochemical Journal|June 8, 2001
Cloning and characterization of human liver cytosolic beta-glycosidaseM de Graaf, I C van Veen, I H van der Meulen-Muileman, et al.
The Journal of Urology|June 7, 2002
Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancerH G van der Poel, B Molenaar, V W van Beusechem, et al.
International Journal of Cancer|March 17, 2001
Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugateP H Houba, E Boven, I H van der Meulen-Muileman, et al.
British Journal of Cancer|February 24, 2001
A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancerP H Houba, E Boven, I H van der Meulen-Muileman, et al.
Biochemical Pharmacology|February 26, 1999
Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenograftsP H Houba, E Boven, I H van der Meulen-Muileman, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and manH J Haisma, M A Kessel, C Silva, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Pageof 8